​

SpringWorks Therapeutics Ownership | Who Owns SpringWorks Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

SpringWorks Therapeutics Ownership Summary

SpringWorks Therapeutics is owned by 51.87% institutional investors, 2.32% insiders, and 45.81% retail investors. Fmr is the largest institutional shareholder, holding 15.02% of SWTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.76% of its assets in SpringWorks Therapeutics shares.

SWTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSpringWorks Therapeutics51.87%2.32%45.81%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.16M15.02%$403.14M
Vanguard group7.16M9.64%$258.65M
Blackrock funding, inc. /de5.96M8.03%$215.35M
Blackrock5.62M7.62%$211.68M
Deep track capital, lp3.46M4.66%$125.04M
Boxer capital3.42M4.64%$128.89M
Price t rowe associates inc /md/3.27M4.41%$118.32M
State street3.09M4.18%$116.28M
Maverick capital2.89M3.89%$104.48M
Pictet asset management sa2.39M3.22%$86.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital3.42M6.79%$128.89M
Velan capital investment management lp185.52K5.78%$6.70M
Oracle investment management254.77K5.01%$9.20M
Deep track capital, lp3.46M4.66%$125.04M
M28 capital management lp110.40K3.92%$3.99M
Bridger management144.53K2.81%$5.22M
Siren1.38M2.20%$49.78M
Ecor1 capital1.56M2.13%$56.36M
Maverick capital2.89M1.88%$104.48M
Ally bridge group (ny)54.69K1.69%$1.98M

Top Buyers

HolderShares% AssetsChange
Ecor1 capital1.56M2.13%1.56M
Capital investors2.36M0.02%1.14M
Polar capital1.00M0.22%650.00K
Pictet asset management sa2.39M0.09%465.49K
Vanguard group7.16M0.00%445.59K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---1.96M
Point72 asset management---1.49M
Deerfield management company, l.p. (series c)---1.28M
Perceptive advisors---692.26K
Candriam s.c.a.164.01K0.03%-681.15K

New Positions

HolderShares% AssetsChangeValue
Ecor1 capital1.56M2.13%1.56M$56.36M
Eagle asset management327.85K0.07%327.85K$12.63M
Raymond james financial291.36K0.00%291.36K$10.53M
Norges bank186.50K0.00%186.50K$6.74M
Velan capital investment management lp185.52K5.78%185.52K$6.70M

Sold Out

HolderChange
Capital performance advisors llp-3.00
Riggs asset managment-7.00
Federated hermes-10.00
Allworth financial lp-12.00
Parallax volatility advisers-16.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024102-55.46%38,519,465-52.09%510.44%63-51.54%26-56.67%
Sep 30, 20242276.57%80,349,0324.19%1080.99%1292.38%5911.32%
Jun 30, 2024213-6.99%77,114,142-0.98%1040.94%126-11.89%53-3.64%
Mar 31, 202422923.12%77,880,4403.37%1051.00%1437.52%5566.67%
Dec 31, 202318624.83%75,339,87710.09%1020.86%13384.72%33-26.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S5.07M6.76%24.43K
Fidelity Growth Compy Commingled Pl O4.81M6.48%13.68K
Fidelity Growth Company Fund3.56M4.74%-
American Funds SMALLCAP World A2.34M3.15%1.13M
Vanguard Total Stock Mkt Idx Inv2.29M3.05%1.58K
Vanguard US Total Market Shares ETF2.10M2.80%2.02K
iShares Russell 2000 ETF1.81M2.42%-15.68K
Vanguard Small Cap Index1.80M2.41%1.47K
Polar Capital Biotech S Inc1.50M2.00%-
US Small-Cap Growth II Equity Comp1.41M1.89%-68.35K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$22.48K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$208.45K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$655.33K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$198.33K
Mar 03, 2025Islam Saqib Chief Executive OfficerSell$625.02K

Insider Transactions Trends

DateBuySell
2025 Q1-25
2024 Q4-4
2024 Q3-6
2024 Q2-12
2024 Q1-10

SWTX Ownership FAQ

Who Owns SpringWorks Therapeutics?

SpringWorks Therapeutics shareholders are primarily institutional investors at 51.87%, followed by 2.32% insiders and 45.81% retail investors. The average institutional ownership in SpringWorks Therapeutics's industry, Biotech Stocks , is 68.48%, which SpringWorks Therapeutics falls below.

Who owns the most shares of SpringWorks Therapeutics?

SpringWorks Therapeutics’s largest shareholders are Fmr (11.16M shares, 15.02%), Vanguard group (7.16M shares, 9.64%), and Blackrock funding, inc. /de (5.96M shares, 8.03%). Together, they hold 32.69% of SpringWorks Therapeutics’s total shares outstanding.

Does Blackrock own SpringWorks Therapeutics?

Yes, BlackRock owns 7.62% of SpringWorks Therapeutics, totaling 5.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 211.68M$. In the last quarter, BlackRock increased its holdings by 180.4K shares, a 3.32% change.

Who is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested?

Boxer capital is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.79% of its assets in 3.42M SpringWorks Therapeutics shares, valued at 128.89M$.

Who is the top mutual fund holder of SpringWorks Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of SpringWorks Therapeutics shares, with 6.76% of its total shares outstanding invested in 5.07M SpringWorks Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools